Chimeric antigen receptor T-cell therapy — assessment and management of toxicities

Overview of attention for article published in Nature Reviews Clinical Oncology, September 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#9 of 2,575)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 35 news outlets
blogs: 2 blogs
policy: 2 policy sources
twitter: 266 X users
patent: 110 patents

facebook: 10 Facebook pages
wikipedia: 1 Wikipedia page
googleplus: 2 Google+ users
reddit: 1 Redditor
guideline: 11 clinical guideline sources

Readers on

mendeley: 1891 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 3 posts from 2 blogs.

Ground-breaking therapy comes with distinct challenges

HematologyTimes, 02 Oct 2018

Attendees at the 13th NCCNhematology congressPhoto courtesy of…

CAR T-Cell Therapy Induces Durable Long-Lasting Responses in Refractory NHL

Online First/Online Only: Posts, 16 Dec 2017

By Mark L. FuerstATLANTA—Responses to chimeric antigen receptor (CAR) T-cell therapy are still strong after 1 year in patients…

Team creates guidelines on CAR T-cell-related toxicity

HematologyTimes, 20 Sep 2017

Sattva Neelapu, MDPhoto courtesy of MDAnderson Cancer CenterResearchers say they have created guidelines for managing the…

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity.